Concepedia

Anna‐Sophia Wiekmeijer

AW

Statistics

Publications

8

Citations

549

H-Index

8

Active since

2011

Affiliations

Leiden University Medical Center(Current)

Erasmus MC

Hospital for Sick Children

ISA Pharmaceuticals (Netherlands)

University of Toronto

Anna‐Sophia Wiekmeijer is an author at Leiden University Medical Center specializing in life sciences, immunology, and stem cell biology.

ORCID

Publications per year

2011–2023

8

Publications

8

Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia

Irene Homminga, Rob Pieters, Anton W. Langerak et al. · Cancer Cell · 2011 · 382 citations · Full text

, , +14

Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus

Martijn H. Brugman, Anna‐Sophia Wiekmeijer, Marja van Eggermond et al. · Proceedings of the National Academy of Sciences · 2015 · 39 citations · Full text

, , +17

Sustained Engraftment of Cryopreserved Human Bone Marrow CD34 <sup>+</sup> Cells in Young Adult NSG Mice

Anna‐Sophia Wiekmeijer, Karin Pike‐Overzet, Martijn H. Brugman et al. · BioResearch open access · 2014 · 37 citations · Full text

, , +16

The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease

Frederike Schmitz, Yvonne Kooy–Winkelaar, Anna‐Sophia Wiekmeijer et al. · Gut · 2015 · 30 citations · Full text

, , +17

Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells

Anna‐Sophia Wiekmeijer, Karin Pike‐Overzet, Hanna IJspeert et al. · Journal of Allergy and Clinical Immunology · 2015 · 29 citations · Full text

, , +14

1–5 of 8